Literature DB >> 14597157

Drug therapeutic failures in emergency department patients. A university hospital experience.

Alessandro Franceschi1, Marco Tuccori, Guido Bocci, Francesca Vannozzi, Antonello Di Paolo, Cecilia Barbara, Marianna Lastella, Corrado Blandizzi, Mario Del Tacca.   

Abstract

Drug therapeutic failure (DTF) could be considered as an adverse drug reaction in which the expected drug effects do not occur following a prescribed pharmacological treatment, including any clinical event that could be related to a low prescribed dose or lack of compliance. DTFs are responsible for increasing disease length, hospitalisation time and social costs, with the worsening of patient quality of life. The aims of the present study are: (1) to estimate the frequency of DTFs among cases of adverse drug events referred to the emergency department; (2) to identify drug classes implicated in DTFs; (3) to analyse the putative causes underlying DTFs. Data presented in this paper were obtained from the Pronto Soccorso and Adverse Drug Events (PSADE) study carried out to analyse drug-related emergency department admissions in several Italian hospitals. Patients, admitted to the emergency department throughout two periods of 10 days each, were interviewed to gain information on their medical status and drug intake during the last two weeks. The present study analysed the patient questionnaires collected in the emergency department of Pisa University Hospital. Among 123 recorded cases of adverse drug event, 41 cases (19:22 male:female ratio; age range: 17-98 years, median age: 75 years) were identified as suspect DTF, resulting in a frequency of 33.33%. A statistical analysis was performed to evaluate the influence of two variables, class of patient age and number of drugs assumed, on DTFs. In accordance with the present findings, showing that the number of drugs assumed by a patient may increase the risk of DTF more than advanced age (odds ratio: 1.371, P<0.02; 1.295, P<0.03, respectively), the prescription of pharmacological combinations might be proposed as a main risk factor for DTF occurrence. In conclusion, our results suggest that DTFs represent an important cause of emergency department admission, particularly in elderly subjects treated with pharmacological associations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14597157     DOI: 10.1016/j.phrs.2003.08.001

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  12 in total

1.  Prevalence of potentially preventable unplanned hospitalizations caused by therapeutic failures and adverse drug withdrawal events among older veterans.

Authors:  Zachary A Marcum; Mary Jo V Pugh; Megan E Amuan; Sherrie L Aspinall; Steven M Handler; Christine M Ruby; Joseph T Hanlon
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-01       Impact factor: 6.053

2.  Therapeutic failure-related hospitalisations in the frail elderly.

Authors:  Robert M Kaiser; Kenneth E Schmader; Carl F Pieper; Catherine I Lindblad; Christine M Ruby; Joseph T Hanlon
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  Mapping of drug-related problems among older adults conciliating medical and pharmaceutical approaches.

Authors:  Marie-Laure Laroche; Thi Hong Van Ngo; Caroline Sirois; Amélie Daveluy; Michel Guillaumin; Marie-Blanche Valnet-Rabier; Muriel Grau; Barbara Roux; Louis Merle
Journal:  Eur Geriatr Med       Date:  2021-03-20       Impact factor: 1.710

4.  Off-label prescribing patterns of antiemetics in children: a multicenter study in Italy.

Authors:  Davide Zanon; Luca Gallelli; Francesca Rovere; Rossella Paparazzo; Natalia Maximova; Marzia Lazzerini; Antonio Reale; Tiziana Corsetti; Salvatore Renna; Tullia Emanueli; Francesco Mannelli; Francesco Manteghetti; Liviana Da Dalt; Caterina Palleria; Nicola Banchieri; Antonio Urbino; Mario Miglietta; Giovanni Cardoni; Adriana Pompilio; Alberto Arrighini; Clara Lazzari; Gianni Messi
Journal:  Eur J Pediatr       Date:  2012-12-04       Impact factor: 3.183

5.  Development of a standardized chart review method to identify drug-related hospital admissions in older people.

Authors:  Stefanie Thevelin; Anne Spinewine; Jean-Baptiste Beuscart; Benoit Boland; Sophie Marien; Fanny Vaillant; Ingeborg Wilting; Ariel Vondeling; Carmen Floriani; Claudio Schneider; Jacques Donzé; Nicolas Rodondi; Shane Cullinan; Denis O'Mahony; Olivia Dalleur
Journal:  Br J Clin Pharmacol       Date:  2018-08-17       Impact factor: 4.335

6.  Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy.

Authors:  Concetta Rafaniello; Flavia Lombardo; Carmen Ferrajolo; Liberata Sportiello; Elisabetta Parretta; Ranieri Formica; Simona Potenza; Barbara Rinaldi; Antonio Irpino; Roberto Raschetti; Nicola Vanacore; Francesco Rossi; Annalisa Capuano
Journal:  Eur J Clin Pharmacol       Date:  2013-10-22       Impact factor: 2.953

7.  Prevalence and perceived preventability of self-reported adverse drug events--a population-based survey of 7099 adults.

Authors:  Katja Marja Hakkarainen; Karolina Andersson Sundell; Max Petzold; Staffan Hägg
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

Review 8.  Understanding adverse drug-related emergency department visits: development of a conceptual model through a systematic review.

Authors:  Abubakar Ibrahim Jatau; Zayyanu Shitu; Garba Mohammed Khalid; Ismaeel Yunusa; Ahmed Awaisu
Journal:  Ther Adv Drug Saf       Date:  2019-06-24

Review 9.  Pharmacokinetic drug-drug interaction and their implication in clinical management.

Authors:  Caterina Palleria; Antonello Di Paolo; Chiara Giofrè; Chiara Caglioti; Giacomo Leuzzi; Antonio Siniscalchi; Giovambattista De Sarro; Luca Gallelli
Journal:  J Res Med Sci       Date:  2013-07       Impact factor: 1.852

10.  Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults.

Authors:  Katja M Hakkarainen; Hanna Gyllensten; Anna K Jönsson; Karolina Andersson Sundell; Max Petzold; Staffan Hägg
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.